Biomedtech Portfolio

PK Med

Locally administered therapeutic products to address inflammatory joint diseases and tissue regeneration

PK Med's Website

PK MED, founded by Truffle Capital in 2019, is a Biotech developing novel drug delivery mechanisms for inflammatory joint diseases (gout flares and osteoarthritis).

LATEST NEWS

February 26, 2024

PK MED Announces FDA Clearance to Initiate its Clinical Programme for PKM-01, for Local Treatment of Gout Flares, Directly by Phase II Trial

OTHER COMPANIES

Skinosive

Bio-adhesive UV filters for long lasting and broad-spectrum sun protection

Caranx Medical

Autonomous robot improving efficiency and safety in Transcatheter Aortic Valve Replacement (TAVI...

BariaTek

Minimally invasive, atraumatic, reversible and endoscopically delivered medical device to treat o...

Artedrone

Autonomous robotic solution to increase the accessibility of mechanical thrombectomy during acute...

Carbios

Biotechnology powering plastic and textile circularity

Affluent Medical

Minimally invasive, biomimetic and adjustable solutions for mitral regurgitation and urinary inco...

Abivax

Regulating the immune response through microRNA

Holistick Medical

Patent Foramen Ovale (PFO) treatment through next generation medical devices

Seacure

Seacure leverages natural processes to fight against coastal erosion and protect marine structures

Theraclion

Medical devices levaraging Focused Ultrasounds to treat varicose veins, Fibroadenoma and Thyroid...